Enzolytics Inc. (ENZC) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Plano, TX, 美国. 现任CEO为 Steven Sharabura.
ENZC 拥有 IPO日期为 2009-04-08, 1 名全职员工, 在 Other OTC, 市值为 $1.18M.
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
